| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/18/2009 | CA2184841C Recombinant adenovirus coding for glial-derived neurotrophic factor (gdnf) |
| 08/13/2009 | WO2009100431A1 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| 08/13/2009 | WO2009100370A1 Methods of treating migraine based on rhythmic sodium levels |
| 08/13/2009 | WO2009100116A1 Oligodendrocyte precursor cell composition and methods of use |
| 08/13/2009 | WO2009099672A2 Breaking immunological tolerance with a genetically encoded unnatural amino acid |
| 08/13/2009 | WO2009099563A2 Combination of a nmda receptor channel blocker and a pkc activator for treatment of alzheimer's disease |
| 08/13/2009 | WO2009099326A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 08/13/2009 | WO2009099221A1 Production method and production device for composition having high content of theobromine |
| 08/13/2009 | WO2009099177A1 Amino imidazole derivative |
| 08/13/2009 | WO2009099176A1 Antibody capable of binding specifically to aβ-oligomer, and use thereof |
| 08/13/2009 | WO2009099087A1 Benzylpiperizine compound |
| 08/13/2009 | WO2009099080A1 Novel phenylpyrrole derivative |
| 08/13/2009 | WO2009098576A1 Pyridinyl amides for the treatment of cns and metabolic disorders |
| 08/13/2009 | WO2009098320A2 Macrolides for treating diseases mediated through pde inhibition |
| 08/13/2009 | WO2009098238A1 Anti-trka antibodies and derivatives thereof |
| 08/13/2009 | WO2009098209A1 Novel 9-aza-bicyclo[3.3.1]non-3-yloxy chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/13/2009 | WO2009098208A1 Novel phenylethynyl derivatives of 8-aza-bicyclo[3.2.1]octane and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/13/2009 | WO2009098193A1 The hemi-fumarate salt of a 1,3,4-thiadiazolyl derivative as modulator of the sphingosine 1-phosphate receptor |
| 08/13/2009 | WO2009098127A1 Biocompatible injectable products with zinc and/or zinc-form saccharide-salt release, and uses thereof |
| 08/13/2009 | WO2009098051A1 Aryl sulfonamides as effective analgesics |
| 08/13/2009 | WO2009098008A2 3-(2-dimethylaminomethyl-cyclohexyl)-phenol against polyneuropathic pain |
| 08/13/2009 | WO2009098000A1 Heterocyclically-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 08/13/2009 | WO2009097999A1 Aryl-substituted imidazolidine-2,4-diones, method for the production thereof, medicaments containing said compounds and use thereof |
| 08/13/2009 | WO2009097996A1 Use of substituted phenylimidazolidines for producing medicaments for treating metabolic syndrome |
| 08/13/2009 | WO2009097995A1 Novel phenyl-substituted imidazolidines, method for the production thereof, medicaments containing said compounds and use thereof |
| 08/13/2009 | WO2009097774A1 The use of aryl piperazine derivatives in manufacturing medicants for treating pain |
| 08/13/2009 | WO2009097695A1 Arylmethylidene heterocycles as novel analgesics |
| 08/13/2009 | WO2009097688A1 Compositions and methods for alleviating depression or improving cognition |
| 08/13/2009 | WO2009075857A3 Glycine transporter-1 inhibitors |
| 08/13/2009 | WO2009067607A3 Combinations of pde4 inhibitors and antipsychotics for the treatment of psychotic disorders |
| 08/13/2009 | WO2009062260A8 Therapy for multiple sclerosis |
| 08/13/2009 | WO2009052073A3 Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists |
| 08/13/2009 | WO2009051660A3 Compounds for activating tgf-beta signaling |
| 08/13/2009 | WO2009050201A3 4-phenyl-5-oxo-imidazole derivatives, pharmaceutical compositions and uses therof |
| 08/13/2009 | WO2009043525A3 Use of the combination of gluten exorphin c and cd36 as a therapeutic agent |
| 08/13/2009 | WO2009043477A3 Use of glpl (7-36) alone or in combination with leptin 22-56 as a therapeutic agent |
| 08/13/2009 | WO2009043453A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009043436A3 Use of af12198 as a therapeutic agent |
| 08/13/2009 | WO2009040031A3 Use of a peptide as a therapeutic agent |
| 08/13/2009 | WO2009039991A3 Use of aviptadil as a therapeutic agent |
| 08/13/2009 | WO2009039964A3 Use of glucagon-like peptide as a therapeutic agent |
| 08/13/2009 | WO2009034475A3 Perharidines as cdk inhibitors |
| 08/13/2009 | WO2009033792A3 Gamma 1 msh alone or in combination with pentagastrin as a therapeutic agent |
| 08/13/2009 | WO2009033770A3 Calcitonin c-terminal flanking peptide for use as a therapeutic agent |
| 08/13/2009 | WO2009019534A3 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 08/13/2009 | WO2009008725A3 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
| 08/13/2009 | WO2008148839A3 Long-acting polymeric prodrugs of exendin |
| 08/13/2009 | WO2008143880A8 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and traumatic brain injury |
| 08/13/2009 | WO2008080268A8 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors |
| 08/13/2009 | US20090203782 Alpha 2 Delta Ligands for Fibromyalgia and Other Disorders |
| 08/13/2009 | US20090203767 Inhibition stat-1 |
| 08/13/2009 | US20090203760 CYCLIC AGONISTS AND ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS |
| 08/13/2009 | US20090203752 Compounds for nonsense suppression, and methods for their use |
| 08/13/2009 | US20090203751 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/13/2009 | US20090203747 Novel chemical compounds and the uses thereof as a medicine |
| 08/13/2009 | US20090203741 Crystals of benzoxadiazole derivative |
| 08/13/2009 | US20090203737 Pyrrole Derivatives as Positive Allosteric Modulators of Metabotropic Receptors |
| 08/13/2009 | US20090203736 Piperidine sulphonamide derivatives |
| 08/13/2009 | US20090203735 Treatments for neuropathy |
| 08/13/2009 | US20090203732 Thiazolones for Use as P13 Kinase Inhibitors |
| 08/13/2009 | US20090203731 Treatment of depression and other affective disorders |
| 08/13/2009 | US20090203722 Novel compositions and methods for enhancing potency or reducing adverse side effects of opiold agonists |
| 08/13/2009 | US20090203719 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 08/13/2009 | US20090203710 Novel piperidine derivative |
| 08/13/2009 | US20090203708 Novel substituted-1-h-quinazoline-2,4-dione derivatives, preparation method thereof and pharmaceutical composition containing the same |
| 08/13/2009 | US20090203707 Methods for treating pain |
| 08/13/2009 | US20090203702 INHIBITORS OF p38 |
| 08/13/2009 | US20090203691 such as N1-{3-[3,5-Di(trifluoromethyl)phenyl]-1H-5-indazolyl}-(2R)-2-amino-3,3-diphenylpropanamide, having an excellent Jun N-terminal Kinase (JNK) inhibitory action, used for treating various immunologic diseases, inflammatory diseases, and/or neurodegenerative diseases |
| 08/13/2009 | US20090203690 5-substituted indazoles as kinase inhibitors |
| 08/13/2009 | US20090203682 Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological Disorders |
| 08/13/2009 | US20090203672 Substituted Sulfonamide Compounds |
| 08/13/2009 | US20090203669 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
| 08/13/2009 | US20090203664 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6- diazabicyclo[3.2.0]heptane |
| 08/13/2009 | US20090203658 Neuroactive steroid compositions and methods of use therefor |
| 08/13/2009 | US20090203644 Compositions for treating and/or preventing diseases characterized by the presence of metal ions |
| 08/13/2009 | US20090203615 Use of activity dependent neurotrophic factor for enhancing learning and memory: pre-and post-natal administration |
| 08/13/2009 | US20090203607 Method And Compositions For Simultaneously Regulating Memory And Mood |
| 08/13/2009 | US20090203122 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 08/13/2009 | US20090202629 Controlled release hydrocodone formulations |
| 08/13/2009 | US20090202627 Methods and compositions for diseases associated with amyloidosis |
| 08/13/2009 | US20090202605 High aspect ratio template and method for producing same for central and peripheral nerve repair |
| 08/13/2009 | US20090202591 Leucine-based motif and clostridial neurotoxins |
| 08/13/2009 | US20090202509 Methods and agents for reducing oxidative stress |
| 08/13/2009 | US20090202506 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma |
| 08/13/2009 | US20090202503 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 08/13/2009 | DE202009006461U1 Kombination von Tocotrienolen mit ungesättigten Fettsäuren als Mittel zum Schutz des Herz/Kreislaufsystems, vor Krebserkrankungen, zur Entzündungshemmung, zur Steigerung der geistigen Leistungsfähigkeit und gegen Altersbeschwerden Combination of tocotrienols with unsaturated fatty acids as a means to protect the heart / circulatory system against cancer, reduces inflammation, increase mental performance and complaints against age |
| 08/13/2009 | DE102008007440A1 Aminosäurederivate als Arzneistoffe Amino acid derivatives as drugs |
| 08/13/2009 | DE102008007381A1 Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten Amidines and guanidines and their derivatives for the treatment of diseases |
| 08/13/2009 | CA2715143A1 Novel phenylpyrrole derivative |
| 08/13/2009 | CA2714966A1 Arylmethylidene heterocycles as novel analgesics |
| 08/13/2009 | CA2714413A1 Antibody capable of binding specifically to ab-oligomer, and use thereof |
| 08/13/2009 | CA2714389A1 Macrolides and uses of macrolides |
| 08/13/2009 | CA2714232A1 Pyridinyl amides for the treatment of cns and metabolic disorders |
| 08/13/2009 | CA2714226A1 Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| 08/13/2009 | CA2714120A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 08/13/2009 | CA2713855A1 Benzylpiperizine compound |
| 08/13/2009 | CA2713786A1 Anti trka antibodies and derivatives thereof |
| 08/13/2009 | CA2712800A1 Compositions and methods for alleviating depression or improving cognition |
| 08/13/2009 | CA2712637A1 3-(2-dimethylaminomethyl-cyclohexyl)-phenol against polyneuropathic pain |
| 08/13/2009 | CA2712582A1 Aryl sulfonamides as effective analgesics |